COL22A1 and glioblastoma: As in our study, we have integrated radiomics and genomics to identify five genes (VAMP8, CYBA, COL22A1, FCER1G, and NPC2) positively correlated with a risk score designed to predict the aggressiveness and potential outcomes of GBM, as well as its potential to trigger AE.